ArticleBMJ open2024

Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis.

Arie Jan Stoppelenburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.